Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Mutation Research|April 18, 2000
The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and factsG Fronza, A Inga, P Monti, et al.Oncogene|June 29, 2001
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elementsP Campomenosi, P Monti, A Aprile, et al.Mutation Research|February 3, 2000
5-methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiationP Monti, A Inga, G Scott, et al.Cancer Research|February 11, 1999
N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenicA Inga, F X Chen, P Monti, et al.International Journal of Cancer|November 10, 2000
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphomaF Fais, G Fronza, S Roncella, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1996
p53 is frequently mutated in Barrett's metaplasia of the intestinal typeP Campomenosi, M Conio, M Bogliolo, et al.The Journal of Biological Chemistry|June 22, 1999
Relationship between DNA methylation and mutational patterns induced by a sequence selective minor groove methylating agentJ D Kelly, A Inga, F X Chen, et al.Cell Death & Disease|June 9, 2018
Correction to: JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stressA Kostecka, A Sznarkowska, K Meller, et al.Cell Death & Disease|October 24, 2014
JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stressA Kostecka, A Sznarkowska, K Meller, et al.Pageof 4